2024 U.S. POC/Decentralized Clinical Chemistry Market: Country Supplier Shares, Test Volume and Sales Segment Forecasts

August 2024 | | ID: 2D272F008EC3EN
Venture Planning Group

Abstracts

This new 373-page report from LeadingMarketResearch.com contains 61 tables, and provides a comprehensive analysis of the POC clinical chemistry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC clinical chemistry market. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.Market Segmentation Analysis%li%Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.%li%Five-year test volume and reagent sales forecasts for clinical chemistry procedures by market segment:%li%Physician Offices/Group Practices %li%Emergency Rooms %li%Operating/Recovery Suites %li%ICUs/CCUs %li%Cancer Clinics %li%Ambulatory Care Centers %li%Surgery Centers %li%Nursing Homes%li%Birth CentersSales and Market Share Analysis%li%Sales and market shares of major clinical chemistry reagent and instrument suppliers.Current and Emerging Products%li%Analysis of clinical chemistry procedures performed in POC testing locations.%li%Review of leading clinical chemistry analyzers, both currently marketed and & those in development, including their operating characteristics, features and selling prices.Technology Review%li%Emerging technologies and their applications for POC testing.%li%Comprehensive listings of companies developing or marketing clinical Chemistry & testing technologies and products, by assay.Competitive Assessments%li%Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.Strategic Recommendations%li%Specific opportunities for new clinical chemistry instruments and reagent systems & with potentially significant market appeal during the next five years.%li%Design criteria for POC testing products.%li%Alternative business expansion strategies.%li%Potential market entry barriers and risks.MethodologyThis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.Contains 373 pages and 61 tables

Contents

Introduction
Executive Summary
Rationale for Testing Decentralization

1. OVERVIEW

2. REGULATORY TRENDS

3. ECONOMIC TRENDS

4. DEMOGRAPHIC TRENDS

5. TECHNOLOGICAL TRENDS

6. SOCIAL TRENDS

7. QUALITY OF CARE

8. DEFENSIVE MEDICINE

9. QUALITY CONTROL ISSUES

Review of Clinical Chemistry Tests

1. ALBUMIN

2. ALKALINE PHOSPHATASE

3. ALT/SGPT

4. AMMONIA

5. AMYLASE

6. AST/SGOT

7. BILIRUBIN

8. BLOOD GASES

9. BLOOD UREA NITROGEN (BUN)

10. CALCIUM

11. CHOLESTEROL

12. CHOLINESTERASE

13. CREATININE

14. ELECTROLYTES

a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
Table of Contents (continued)

15. FERRITIN

16. FOLLATE/FOLIC ACID

17. FRUCTOSAMINE

18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)

19. GLUCOSE

20. HIGH DENSITY LIPOPROTEIN (HDL)

21. IRON

22. LACTATE DEHYDROGENASE (LDH)

23. MAGNESIUM

24. PHOSPHORUS

25. PROTEIN

26. TRIGLYCERIDES

27. TROPONIN

28. URIC ACID

29. URINALYSIS

30. VITAMIN B12

Instrumentation: Chemistry Analyzers Manufactured by:
- Abaxis
- Abbott
- Alfa Wassermann
- Awareness Technologies
- Beckman Coulter/Danaher
- bioMeriuex
- Carolina Chemistries
- Horiba
- Inverness
- Medica
- Nova Biomedical
- Ortho-Clinical Diagnostics
- Polimedco
- Randox
- Roche
Current and Emerging Technologies

1. MONOCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
b. Enzyme Immunoassays (EIA)